Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL77614 | 1.00 | F10 (0.80) | F10F2 | |
| SCHEMBL14820412 | 0.90 | F10 (0.84) | F10F2 | |
| SCHEMBL77678 | 0.89 | F10 (0.77) | F10F2 | |
| SCHEMBL78395 | 0.89 | F10 (1.00) | F10F2 | |
| SCHEMBL77041 | 0.88 | F10 (0.84) | F10F2 | |
| SCHEMBL77930 | 0.87 | F10 (1.00) | F10F2 | |
| SCHEMBL77189 | 0.86 | F10 (1.00) | F10F2 | |
| SCHEMBL13232277 | 0.85 | F10 (0.82) | F10F2 | |
| SCHEMBL7252255 | 0.85 | F10 (0.68) | F10F2 | |
| SCHEMBL7252252 | 0.85 | F10 (0.68) | F10F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160303138-A1 | Combination Therapy Of Substituted Oxazolidinones | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2016-10-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160303138-A1 | Combination Therapy Of Substituted Oxazolidinones | P2RY12, P2RY11, P2RY1 | F10 1174/4885F2 398/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.